Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a bridging regimen containing mitoxantrone hydrochloride liposome injection together with CD19-targeting CAR-T therapie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoma

Drugs mentioned

• CD19-targeting CAR-T therapy (CAR-T cell therapy)
• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Refractory | Phase 2 | Status: ACTIVE_NOT_RECRUITING